Affordable cancer treatments available

Even more disturbing, low-cost pain relief medications remain largely inaccessible to patients in developing countries, meaning that most people with cancer worldwide suffer tremendous pain  — needlessly — before they die, the report’s authors say.

These findings come from the report, “Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries,” being released today by an international group of experts organized by the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries (GTF.CCC), and hosted by a consortium of organizations that includes Harvard School of Public Health, Harvard Global Equity Initiative, Harvard Medical School, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Partners In Health.

Once considered a problem only in wealthy countries, cancer is now a leading cause of death in low- and middle-income countries. About 55 percent of the world’s 12.7 million new cases and 65 percent of the 7.6 million cancer deaths each year occur in these nations.

The report was discussed at a daylong symposium Oct. 28 at Harvard Medical School. It was attended by representatives from national governments from low- and middle-income countries, global and national civil society organizations, the private sector, academia, and donors.

---

This story is published courtesy of the Harvard Gazette, Harvard University’s official newspaper. For additional university news, visit Harvard.edu.

Provided by Harvard University